Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine presurgical pilot study in breast cancer
NL-OMON34049Phase 2Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of hydroxychloroquine in breast cancer, sponsored by Radboud University Medical Center. Primary endpoints: Change in endogenous hypoxia markers and Change in autophagy marker LC3b. Started Jan 2011; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON34049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34049.